CHINA PHARMA HOLDINGS, INC. (CPHI) Current Reports & Earnings Releases
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-07-22 | 8-K | Material Agreement, Other Events, Financial Statements & Exhibits | SEC |
| 2026-03-03 | 8-K | Material Agreement, Unregistered Sales, Financial Statements & Exhibits | SEC |
| 2026-02-10 | 8-K | Material Agreement, Unregistered Sales, Financial Statements & Exhibits | SEC |
| 2026-01-06 | 8-K | Shareholder Vote Results | SEC |
| 2025-12-23 | 8-K | Material Agreement, Unregistered Sales | SEC |
| 2025-12-10 | 8-K | Material Agreement, Unregistered Sales | SEC |
| 2025-04-04 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-12-26 | 8-K | Shareholder Vote Results | SEC |
| 2024-12-26 | 8-K | Termination of Agreement | SEC |
| 2024-12-13 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2024-05-30 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2024-05-08 | 8-K | Auditor Change | SEC |
| 2024-03-29 | 8-K | Other Events | SEC |
| 2024-02-23 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-02-08 | 8-K | Material Agreement, Unregistered Sales | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.